RESMED INC — Director's Dealing 2018

Nov 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-21

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-21	ResMed Common Stock	A	103558	$104.18	Acquired	344045	Direct
2018-11-21	ResMed Common Stock	F	57763	$104.18	Disposed	286282	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	10340	Indirect

Footnotes

F1: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on November 21, 2018, when the compensation committee certified that the performance metrics were met.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.